Cubist Systematic Strategies, LLC Opti Nose, Inc. Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.63 - $2.02 $23,775 - $29,463	14,586 New	14,586 $28,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.16 $39,834 - $53,565	-16,951 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.91 - $3.83 $38,065 - $50,100	-13,081 Reduced 43.56%	16,951 $53,000
Q1 2021 May 17, 2021	SELL	$3.47 - $4.75 $51,581 - $70,608	-14,865 Reduced 33.11%	30,032 $111,000
Q4 2020 Feb 16, 2021	BUY	$3.2 - $4.98 $143,670 - $223,587	44,897 New	44,897 $186,000
Q3 2019 Nov 14, 2019	SELL	$4.75 - $8.38 $54,829 - $96,730	-11,543 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.4 - $10.94 $73,875 - $126,280	11,543 New	11,543 $82,000
Q1 2019 May 15, 2019	SELL	$6.1 - $10.3 $257,133 - $434,175	-42,153 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.84 - $11.92 $246,173 - $502,463	42,153 New	42,153 $261,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.